journal
https://read.qxmd.com/read/38591208/an-epic-advancement-in-targeting-macrophages-for-cancer-therapy-approach
#1
JOURNAL ARTICLE
Lu Xiaohong, Fu Qiuxia, Li Ruie, Wang Daijie, Tobias Achu Muluh, Yan Zhang
Macrophages are immune cells with high heterogeneity and plasticity, crucial for recognizing and eliminating foreign substances, including cancer cells. However, cancer cells can evade the immune system by producing signals that cause macrophages to switch to a pro-tumor phenotype, promoting tumor growth and progression. Tumor-associated macrophages, which infiltrate into tumor tissue, are important immune cells in the tumor microenvironment and can regulate cancer's growth, invasion, and metastasis by inhibiting tumor immunity...
April 8, 2024: Current Drug Delivery
https://read.qxmd.com/read/38500282/preparation-characterization-and-hepatoprotective-activity-evaluation-of-quercetin-loaded-pluronic%C3%A2-f127-chitosan-myristic-acid-mixed-micelles
#2
JOURNAL ARTICLE
Darshan R Telange, Seema Kamdi, Atul T Hemke, Anil M Pethe, Vijay B Lambole, Umesh B Telrandhe
BACKGROUND: Quercetin (QTN) is a flavonol antioxidant found in foods, medicinal plants, fruits, vegetables, and beverages. QTN oral consumption produces several biological effects, including antioxidant, cardioprotective, anti-apoptotic, anti-cancer, neuroprotection, anti-hypertensive, and chemo preventive. OBJECTIVE: The study aimed to prepare Pluronic®F127/chitosan-myristic acid copolymer (PF127/C-MAc)-based mixed micelles (QTN MM) to improve the biopharmaceutical and hepatoprotective potential of QTN...
March 18, 2024: Current Drug Delivery
https://read.qxmd.com/read/38445697/advances-in-aerosol-formulation-for-targeted-delivery-of-therapeutic-agents-from-nose-to-brain
#3
JOURNAL ARTICLE
Shristy Verma, Pramod Kumar Sharma, Rishabha Malviya
The intricate anatomical and physiological barriers that prohibit pharmaceuticals from entering the brain continue to provide a noteworthy hurdle to the efficient distribution of medications to brain tissues. These barriers prevent the movement of active therapeutic agents into the brain. The present manuscript aims to describe the various aspects of brain-targeted drug delivery through the nasal route. The primary transport mechanism for drug absorption from the nose to the brain is the paracellular/extracellular mechanism, which allows for rapid drug transfer...
March 5, 2024: Current Drug Delivery
https://read.qxmd.com/read/38445696/recent-trends-and-applications-of-nanostructure-based-drug-delivery-in-alleviating-chronic-obstructive-pulmonary-disease-copd
#4
JOURNAL ARTICLE
Lokesh, Nisha Gulati, Annu Saini, Sachin Singh, Gaurav Gupta, Ronan MacLoughlin, Dinesh Kumar Chellappan, Kamal Dua, Harish Dureja
Chronic Obstructive Pulmonary Disease (COPD), a chronic lung disease that causes breathing difficulties and obstructs airflow from the lungs, has a significant global health burden and affects millions of people worldwide. The use of pharmaceuticals in COPD treatment is aimed to alleviate symptoms, improve lung function, prevent exacerbations, and enhance the overall quality of life for patients. Nanotechnology holds great promise to alleviate the burden of COPD. The main goal of this review is to present the full spectrum of therapeutics based on nanostructures for the treatment and management of COPD, including nanoparticles, polymeric nanoparticles, polymeric micelles, solid-lipid nanoparticles, liposomes, exosomes, nanoemulsions, nanosuspensions, and niosomes...
March 5, 2024: Current Drug Delivery
https://read.qxmd.com/read/38441019/volatile-oil-of-magnolia-biondii-pamp-for-transnasal-administration-its-preparation-characterization-and-mechanism-of-action-in-the-treatment-of-allergic-rhinitis
#5
JOURNAL ARTICLE
Qiuting Guo, Xuan Wang, Yao Wang, Peijie Zhou, Xiaofei Zhang
BACKGROUND: Allergic Rhinitis (AR) is a common chronic nasal condition usually caused by allergens. The immune system overreacts when the body is exposed to allergens, releasing a lot of tissue chemicals that cause congestion, more secretions, and an inflammatory reaction in the nasal mucosa. METHOD: In clinical practice, it remains a significant public health issue. Modern pharmacological studies have demonstrated that Magnolia Volatile Oil (MVO) has good anti-inflammatory, antibacterial, immunomodulatory, and other pharmacological effects...
March 1, 2024: Current Drug Delivery
https://read.qxmd.com/read/38425111/review-of-phytosomes-and-ethosomes-groundbreaking-approaches-for-delivering-the-phytochemical-components-of-plants
#6
JOURNAL ARTICLE
Asha Raghav, Meenakshi Attri, Hema Chaudhary
Phytoconstituents have been widely used since ancient times to form a complex with phospholipids due to their various therapeutic actions. Despite having strong pharmacodynamic efficiency, numerous phytoconstituents have shown lower in vivo bioavailability and few adverse effects. Phytochemicals soluble in water exhibit poor absorption, leading to a limited therapeutic impact. Phytosome nanotechnology overcomes this limitation by creating a bound of phytochemicals with phospholipids. This method exhibits improved absorption because phytosomes inhibit significant herbal extract components from being degraded by gastric juices and gut flora...
February 29, 2024: Current Drug Delivery
https://read.qxmd.com/read/38425110/targeted-bacterial-keratitis-treatment-with-polyethylene-glycol-dithiothreitol-boric-acid-hydrogel-and-gatifloxacin
#7
JOURNAL ARTICLE
Xiao Shen, Chunlian Huang, Jian-Hai Bai, Jing Wen
OBJECTIVE: To prolong the ocular residence time of gatifloxacin and enhance its efficacy against bacterial keratitis, this study developed a velocity-controlled polyethylene glycol-dithiothreitol- boric acid (PDB) hydrogel loaded with gatifloxacin. MATERIALS AND METHODS: First, the basic properties of the synthesized PDB hydrogel and the gatifloxacin- loaded PDB hydrogel were assessed. Secondly, the in vitro degradation rate of the drugloaded PDB was measured in a simulated body fluid environment with pH 7...
February 29, 2024: Current Drug Delivery
https://read.qxmd.com/read/38424427/an-enzyme-responsive-porphyrin-metal-organic-framework-nanosystem-for-targeted-and-enhanced-synergistic-cancer-photo-chemo-therapy
#8
JOURNAL ARTICLE
Mengqi Yi, Yangxin Lin, Yuyang Li, Bei Xiong, Yunhan Huang, Wei Guo, Bo Lu
BACKGROUND: The clinical efficiency of photodynamic therapy (PDT) in combination with chemotherapy has proven to be a promising strategy for tumor treatment, yet is restricted by the high glutathione (GSH) concentration at the tumor site and nonspecific drug targeting. OBJECTIVE: The goal of the current research was to create a biocompatible GSH-depleting and tumor- targeting nanoparticle (denoted as DOX/CA@PCN-224@HA) for the combined photodynamic and chemo photo-chemo) therapy...
February 27, 2024: Current Drug Delivery
https://read.qxmd.com/read/38409707/current-progress-and-emerging-role-of-essential-oils-in-drug-delivery-therapeutics
#9
JOURNAL ARTICLE
Rokeya Sultana, Sourav Mohanto, Adrija Bhunia, Aritra Biswas, Mohammad Shabib Akhtar, Vijay Mishra, Dimple Modi, Alaa Aa Aljabali, Murtaza Tambuwala, Md Faiyazuddin
The utilization of novel drug delivery systems loaded with essential oils has gained significant attention as a promising approach for biomedical applications in recent years. Plants possess essential oils that exhibit various medicinal properties, i.e., anti-oxidant, anti-microbial, anti- inflammatory, anti-cancer, immunomodulatory, etc., due to the presence of various phytoconstituents, including terpenes, phenols, aldehydes, ketones, alcohols, and esters. An understanding of conventional and advanced extraction techniques of Essential Oils (EOs) from several plant sources is further required before considering or loading EOs into drug delivery systems...
February 22, 2024: Current Drug Delivery
https://read.qxmd.com/read/38385485/transfersomes-recent-advances-mechanisms-exhaustive-applications-clinical-trials-and-patents
#10
JOURNAL ARTICLE
Deeksha Manchanda, Manish Makhija, Parijat Pandey, Manu Sharma
A feasible nano transdermal delivery system generally intends to have specific ideal and distinct characteristics primarily for safety, clinical efficacy, and boosted therapeutic index. The delivery of drugs, particularly macromolecules, across the skin is one of the most strenuous obstacles in front of pharmaceutical scientists. Technology advancement has provided some opportunities to overcome this difficulty by utilising microneedle arrays, ablation, laser methods etc. However, associated uneasiness, painful sensation, and higher cost of therapies limit their day-to-day use...
February 21, 2024: Current Drug Delivery
https://read.qxmd.com/read/38549518/resveratrol-based-delivery-systems-as-contemporary-nominees-for-combating-pulmonary-diseases-a-comprehensive-review
#11
JOURNAL ARTICLE
Sara Ahmed, Mai Mansour, Rania A H Ishak, Nahed D Mortada
Exploiting different formulation approaches, each designed to improve the clinical use of resveratrol (RES) in treating several lung diseases. Accentuating the rationale for using RESbased delivery systems in different clinical applications in pulmonary diseases. Resveratrol (RES), a well-known natural polyphenol stilbenoid, possesses tremendous potential to treat various lung diseases owing to its anti-inflammatory, antioxidant, antiapoptotic, antiviral, and anticancer activities. Its physicochemical properties have restricted the beneficial activities of resveratrol, as it is characterized by low aqueous solubility, bioavailability and stability in addition to high photosensitivity...
February 16, 2024: Current Drug Delivery
https://read.qxmd.com/read/38362691/designing-optimising-and-assessing-a-novel-emulgel-containing-minoxidil-for-controlled-drug-release-incorporating-marine-based-polymers
#12
JOURNAL ARTICLE
Flowerlet Mathew, A Mary Saral
OBJECTIVE: This study aimed to develop an emulgel containing minoxidil as a drug for hair growth promotion in diseases, such as androgenetic alopecia, using gelling agents, such as chitosan and fucoidan. METHODS: In this study, gelling agents were selected for the emulgel formulation. By various evaluation tests and through optimization, the chitosan-fucoidan combination was selected as the gelling agent for the preparation of emulgel using various evaluation parameters...
February 15, 2024: Current Drug Delivery
https://read.qxmd.com/read/38299275/emerging-phytochemical-formulations-for-management-of-rheumatoid-arthritis-a-review
#13
JOURNAL ARTICLE
Prachi Pimple, Jenny Shah, Prabha Singh
Rheumatoid arthritis (RA) is a T-cell-mediated chronic inflammatory disorder affecting 0.5-1% of the global population. The disease with unknown etiology causes slow destruction of joints, advancing to significant deterioration of an individual's quality of life. The present treatment strategy comprises the use of disease-modifying anti-rheumatic drugs (DMARDs) coupled with or without nonsteroidal anti-inflammatory drugs or glucocorticoids. Additionally, involves co-therapy of injectable biological DMARDs in case of persistent or recurrent arthritis...
January 30, 2024: Current Drug Delivery
https://read.qxmd.com/read/38299274/influence-of-nano-particulate-impurities-and-%C3%AE-glucans-on-the-stability-of-protein-based-formulations
#14
JOURNAL ARTICLE
Soumya Ranjan Satapathy, Rudra Narayan Sahoo, Amit Kumar Nayak
Pharmaceutical grade sugars manufactured under Current Good Manufacturing Practice (cGMP) and complied with International Pharmaceutical Excipients Council (IPEC) quality standards, also contain a significant amount of nano-particulate impurities (NPIs). This review will focus on the origin of NPIs, the mechanism of their interference with Dynamic light scattering (DLS) and endotoxin tests, filtration technology to effectively reduce the NPIs, methodologies for analytical quantification of NPIs, guidance for setting the limits of threshold concentration and the overall impact of NPIs on the therapeutic activity, performance, stability of biopharmaceuticals and protein-based formulations...
January 30, 2024: Current Drug Delivery
https://read.qxmd.com/read/38310439/intelligent-drug-delivery-pioneering-stimuli-responsive-systems-to-revolutionize-disease-management-an-in-depth-exploration
#15
JOURNAL ARTICLE
Badarinadh Kallepalli, Unnati Garg, Neha Jain, Rohan Nagpal, Sakshi Malhotra, Triveni Tiwari, Shreya Kaul, Upendra Nagaich
In recent years, there has been an escalating interest in stimuli-responsive drug delivery systems (SRDDS) due to their ability to revolutionize the delivery of therapeutics. SRDDSs offer a multitude of benefits in comparison to conventional drug delivery systems (DDS), including spatiotemporal control of drug release, targeted delivery, and improved therapeutic efficacy. The development of various classes of stimuli-responsive DDS, such as pH-responsive, temperature-responsive, photo-responsive, redox responsive systems, has been propelled by advances in materials science, nanotechnology, and biotechnology...
January 26, 2024: Current Drug Delivery
https://read.qxmd.com/read/38288800/smart-ultrasound-responsive-polymers-for-drug-delivery-an-overview-on-advanced-stimuli-sensitive-materials-and-techniques
#16
JOURNAL ARTICLE
Mostafa Yazdan, Seyed Morteza Naghib
In recent years, a notable advancement has occurred in the domain of drug delivery systems via the integration of intelligent polymers that respond to ultrasound. The implementation of this groundbreaking methodology has significantly revolutionised the controlled and precise delivery of therapeutic interventions. An in-depth investigation is conducted into the most recent developments in ultrasonic stimulus-responsive materials and techniques for the purpose of accomplishing precise medication administration...
January 26, 2024: Current Drug Delivery
https://read.qxmd.com/read/38279740/fiber-technology-in-drug-delivery-and-pharmaceuticals
#17
JOURNAL ARTICLE
Shivang Dhoundiyal, Aditya Sharma, Md Aftab Alam
The field of fiber technology is a dynamic and innovative domain that offers novel solutions for controlled and targeted therapeutic interventions. This abstract provides an overview of key aspects within this field, encompassing a range of techniques, applications, commercial developments, intellectual property, and regulatory considerations. The foundational introduction establishes the significance of fiber-based drug delivery systems. Electrospinning, a pivotal technique, has been explored in this paper, along with its various methods and applications...
January 25, 2024: Current Drug Delivery
https://read.qxmd.com/read/38279739/a-comprehensive-review-on-polyphenols-based-nanovesicular-system-for-topical-delivery
#18
JOURNAL ARTICLE
Anshu Singh, Zeeshan Fatima, Dipti Srivastava
BACKGROUND: Polyphenols are naturally occurring compounds having more than one hydroxy functional group. They are ubiquitous secondary plant metabolites possessing a wide range of pharmacological activity. Brightly colored fruits and vegetables are the natural source of polyphenols. Majorly, they possess antioxidant, anti-inflammatory and antimicrobial properties which make them suitable candidates to target skin related disorders. OBJECTIVE: This study is focused to explore the potential of polyphenols loaded nanovesicles for skin related disorders...
January 24, 2024: Current Drug Delivery
https://read.qxmd.com/read/38275045/convection-enhanced-diffusion-a-novel-tactics-to-crack-the-bbb
#19
JOURNAL ARTICLE
Meenakshi Dhanawat, Garima, Kashish Wilson, Sumeet Gupta, Rishabh Chalotra, Nidhi Gupta
Although the brain is very accessible to nutrition and oxygen, it can be difficult to deliver medications to malignant brain tumours. To get around some of these issues and enable the use of therapeutic pharmacological substances that wouldn't typically cross the blood-brain barrier (BBB), convection-enhanced delivery (CED) has been developed. It is a cutting-edge strategy that gets beyond the blood-brain barrier and enables targeted drug administration to treat different neurological conditions such as brain tumours, Parkinson's disease, and epilepsy...
January 24, 2024: Current Drug Delivery
https://read.qxmd.com/read/38275044/recent-advancement-in-inhaled-nano-drug-delivery-for-pulmonary-nasal-and-nose-to-brain-diseases
#20
JOURNAL ARTICLE
Qiuxia Fu, Yangjie Liu, Cao Peng, Tobias Achu Muluh, Umer Anayyat, Liu Liang
Pulmonary, nasal, and nose-to-brain diseases involve clinical approaches, such as bronchodilators, inhaled steroids, oxygen therapy, antibiotics, antihistamines, nasal steroids, decongestants, intranasal drug delivery, neurostimulation, and surgery to treat patients. However, systemic medicines have serious adverse effects, necessitating the development of inhaled formulations that allow precise drug delivery to the airways with minimum systemic drug exposure. Particle size, surface charge, biocompatibility, drug capacity, and mucoadhesive are unique chemical and physical features that must be considered for pulmonary and nasal delivery routes due to anatomical and permeability considerations...
January 24, 2024: Current Drug Delivery
journal
journal
40648
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.